Eli Lilly Forecasts Profit, Revenue Drop In 2014

The Associated Press


Eli Lilly expects a sharp drop in both earnings and revenue next year, as the drug developer deals with the loss of patents protecting two more key drugs from cheaper generic competition.

This premium content is reserved for Daily Business Review subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202636628328

Thank you!

This article's comments will be reviewed.